Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples